13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE Filed 2025-02-25 Event 2025-02-21 SEC 0000947871-25-000222 →

TPG GP A, LLC TPG Inc. TPGXL

Stake: 68.50% Shares: 248,441,034 CUSIP: 872657101 Class: Class A Common Stock, $0.001 par value per share

Item 4 — Purpose of Transaction

This Amendment amends and supplements Item 4 of the Original Schedule 13D by inserting the following before the penultimate paragraph: "On November 27, 2024, Mr. Winkelried made a bona fide gift of 100,000 shares of Class A Common Stock to a charitable organization for which no payment or consideration was received. Q1 2025 Exchange Pursuant to the Exchange Agreement, on February 21, 2025, 9,786,354 Common Units were ultimately distributed to certain partners of TPG Partner Holdings, L.P. and the API Entities in connection with the exchange by such partners of those Common Units for an equal number of shares of Class A Common Stock and the cancellation of an equal number of shares of Class B Common Stock (the "Q1 2025 Exchange")."

Cross-References

Insider Activity (last 365d)
11 transactions
11 buys · 0 sales · 0 awards/exercises
Issuer Cluster
5 13D/G filings on this issuer
4 other filings besides this one
Filer Track Record
19 filings by this filer
18 other filings in the data moat
Short Interest · settle 2026-08-14
DTC 1.00
5,031 shares short · -73.7% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $47.86M
Point72 Asset Mgmt

Post-Filing Returns · since 2025-02-21 on TPGXL

+1 day
0.0%
+5 days
0.0%
+30 days
0.0%
+60 days
0.0%
+90 days
0.0%
+180 days
0.0%

Anchor price 23.69 on closest trading day on/after 2025-02-21. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-08-05 WINKELRIED JON director, officer, 10%+ owner Award 1,152
2026-08-05 WINKELRIED JON director, officer, 10%+ owner Award 357
2026-08-05 WINKELRIED JON director, officer, 10%+ owner Award 179
2026-08-05 Vazquez-Ubarri Anilu director, officer Award 155
2026-08-05 Trujillo David director Award 630
2026-08-05 Sisitsky Todd Benjamin director, officer Award 984
2026-08-05 Sisitsky Todd Benjamin director, officer Award 98
2026-08-05 Sarvananthan Ganendran director Award 263
2026-08-05 Rhodes Jeffrey K. director Award 620
2026-08-05 Raj Nehal director Award 382
2026-08-05 Harris Joann officer Award 38

Other 13D/G Filings on TPG Inc.

FiledFormFilerStakeShares
2026-08-18 SCHEDULE 13D/A TPG GP A, LLC 210,848,910 view →
2026-06-17 SCHEDULE 13G INTEGRATED CORE STRATEGIES (US) LLC view →
2026-05-18 SCHEDULE 13D/A TPG GP A, LLC 217,809,708 view →
2024-11-18 SC TPG GP A, LLC view →

Other Filings by TPG GP A, LLC

FiledFormIssuerStakeShares
2026-08-18 SCHEDULE 13D/A TPG Inc. 210,848,910 view →
2026-07-31 SCHEDULE 13D/A TPG Twin Brook Capital Income Fund 21.30% 23,342,573.94 view →
2026-07-01 SCHEDULE 13D/A TPG Twin Brook Capital Income Fund 21,349,053.96 view →
2026-05-26 SCHEDULE 13D/A Life Time Group Holdings, Inc. LTH 9,476,069 view →
2026-05-18 SCHEDULE 13D/A TPG Inc. TPGXL 217,809,708 view →
2026-05-18 SCHEDULE 13D Odyssey Therapeutics, Inc. ODTX 7.80% 3,690,146 view →
2026-04-24 SCHEDULE 13D ACHIEVE LIFE SCIENCES, INC. ACHV 12.60% 13,755,160 view →
2026-01-13 SCHEDULE Anywhere Real Estate Inc. view →
2025-09-15 SCHEDULE Life Time Group Holdings, Inc. LTH 8.10% 17,830,652 view →
2024-11-18 SC TPG Inc. TPGXL view →
2023-07-14 SC Super League Gaming, Inc. SLE view →
2022-01-19 SC Amneal Pharmaceuticals, Inc. AMRX view →
2022-01-18 SC Life Time Group Holdings, Inc. LTH view →
2022-01-18 SC Allogene Therapeutics, Inc. ALLO view →
2022-01-18 SC Rallybio Corp RLYB view →
2022-01-18 SC Fusion Pharmaceuticals Inc. view →
2022-01-18 SC SUPERIOR INDUSTRIES INTERNATIONAL INC view →
2022-01-18 SC Entasis Therapeutics Holdings Inc. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →